Screener
Sionna Therapeutics SION Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Sionna Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Sionna Therapeutics’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 7:17 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-033876
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Accrued expenses | 6,328 | 9,668 |
| Operating lease liability, current | 1,322 | 1,269 |
| Other current liabilities | 17 | 6 |
| Total current liabilities | 9,776 | 11,712 |
| Operating lease liability, noncurrent | 7,055 | 7,408 |
| Total liabilities | 16,831 | 19,120 |
| Stockholders’ equity: | ||
| Preferred stock, $0.001 par value, 10,000,000 shares authorized as of March 31, 2026 and December 31, 2025, respectively; no shares issued or outstanding as of March 31, 2026 and December 31, 2025 | — | — |
Item 1. Financial Statements
FAQ
- What is Sionna Therapeutics's total current liabilities?
- Sionna Therapeutics (SION) reported total current liabilities of $9.78M in Q1 2026.
- How has Sionna Therapeutics's total current liabilities changed year-over-year?
- Sionna Therapeutics's total current liabilities increased by 2.6% year-over-year, from $9.53M to $9.78M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Sionna Therapeutics's total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude